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Abstract 
Organoid methodology provides a platform for the ex vivo investigation of the cellular and molecular 
mechanisms underlying brain development and disease. High-grade brain tumor glioblastoma 
multiforme (GBM) is considered a cancer of unmet clinical need, in part due to GBM cell infiltration 
into healthy brain parenchyma making complete surgical resection improbable. Modelling the process 
of GBM invasion in real time is challenging as it requires both tumor and neural tissue compartments. 
Here, we demonstrate that human GBM spheroids possess the ability to spontaneously infiltrate early-
stage cerebral organoids (eCO). The resulting formation of hybrid organoids demonstrated an invasive 
tumor phenotype that was distinct from non-cancerous adult neural progenitor (NP) spheroid 
incorporation into eCOs. These findings provide a basis for the modelling and quantification of the 
GBM infiltration process using a stem cell-based organoid approach, and may be used for the 
identification of anti-GBM invasion strategies.      
 
Introduction 
GBM is the most aggressive type of brain cancer and is associated with a median survival of A?15 
months from diagnosis.1 Therapeutic intervention (including surgical debulking, radiotherapy, and 
chemotherapy) fails to effectively eliminate the entirety of the tumor and the rate of tumor recurrence 
remains high.2 One aspect of GBM biology that poses a major therapeutic challenge is the diffuse GBM 
cell invasion into normal surrounding brain.3-5 Emerging experimental and histological evidence 
indicates that GBM cell migration is accompanied by the expression of stem cell markers and can be 
predictive of patient outcomes.6-8 Therefore, interventions that specifically target the invasive GBM 
phenotype are highly desirable. However, the molecular mechanisms underlying the infiltrative nature 
of GBM cells are not well understood. Furthermore, it is challenging to develop experimental 
strategies that enable the ex vivo investigation of GBM infiltration into brain-like/neural tissue.  
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Previous studies have shown invasiveness of xenografted GBM stem-like cells in the rodent brain.9-11 
Moreover, confocal microscopy has been used to visualize glioma cell migration in rodent brain 
aggregates and organotypic brain slice models.12-15 This body of work, and recent advances in organoid 
technology,16 motivated the ex vivo development of a throughput-compatible biological assay. We 
based our methodology on neural tissue infiltration by free-floating human GBM and NP spheroids in 
co-culture with mouse embryonic stem cell (mESC)-derived eCOs. Interestingly, we observed a 
pronounced eCO infiltration by GBM compared with NP spheroids, thus providing an exclusively cell-
based experimental approach for the analysis of invasive GBM cellular tissue compartments in 3 
dimensions and real time. 
 
Materials and Methods     
Cell culture  
The generation and characterization of the GBM1 and NP1 cell models has been previously 
described.17 GBM1 cells were cultured in Neurobasal medium (Gibco; 21103-049), supplemented with 
0.5x B-27 (Gibco; 17504-044), 0.5x N-2 (Gibco; 17502-048), recombinant human basic fibroblast 
growth factor (bFGF; 40ng/ml; Gibco; PHG0024) and recombinant human epidermal growth factor 
(rhEGF; 40 ng/mL; R&D; 236-EG). Cells were maintained in a humidified incubator with 5% CO2 at 37°C 
on poly-L-ornithine (5 ʅŐ ?ŵ>; Sigma P3655) and laminin-coated (5 ʅŐ ?ŵ>; Invitrogen; 23017-015) cell 
culture flasks. NP1 cells were cultured in DMEM/F-12 medium (Gibco; 2133-020) supplemented with 
bFGF (40 ng/mL), rhEGF (40 ng/mL), 0.5x B-27, 0.5x N-2, 1x GlutaMAX (Gibco; 35050-038) and 5% (v/v) 
fetal bovine serum (FBS, Gibco; 10270) at 37°C with 5% CO2.  
GFP-expressing lentiviral particles were produced with pFUGW plasmid using a third-generation 
lentiviral system and HEK 293T cells. Viral particles were added to the cells at an MOI of 3.07. Spheres 
were generated through seeding and aggregation of 500 single GBM1 or NP1 cells (each cell line 
cultured in its respective media as stated above) in ultra-low attachment (ULA) 96-well plates 
(Corning; 7007). 
Cerebral organoid development and eCO/GBM and eCO/NP assays  
Mouse cerebral organoids were developed using R1 mESCs as described in18 with minor modifications 
starting from differentiation day 6. R1 mESCs  were cultured on mitotically inactivated mouse 
embryonic fibroblasts (MEF) in media consisting of DulbĞĐĐŽ ?ƐŵŽĚŝĨŝĞĚĞĂŐůĞŵĞĚŝƵŵŚŝŐŚŐůƵĐŽƐĞ
(DMEM-HG; Gibco;11960-044) supplemented with 15% (v/v) knockout serum replacement (KSR; 
Gibco; 10828-028 ), 0.1 mM minimum essential medium non-essential amino acids solution (MEM-
NEAA; Gibco;11140-035), 2 mM glutamine (Gibco; 10378-016), 1 mM sodium pyruvate (Gibco; 11360-
039), 0.1 mM ɴ-mercaptoethanol (Sigma; M3148) and leukaemia inhibitory factor (LIF; 1000U/mL; 
Millipore;ESG1106) at 37°C with 5% CO2. Cells were trypsinized once they reached 70-80% confluency 
and separated from the MEF cells by differential adherence of these to gelatinized plates. 
Subsequently, 2000 dissociated R1 mESCs were plated in ULA 96-well plates. The cell suspension was 
cultured in differentiation media consisting of Glasgow minimum essential medium (GMEM; Sigma; 
G5154) supplemented with 10% KSR, 2 mM glutamine, 1 mM sodium pyruvate, 0.1 mM MEM-NEAA, 
0.1 mM ɴ-mercaptoethanol and 10 ʅM SB431542 (Sigma; S4317) for 4 days as previously described. 
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The resulting embryoid bodies were transferred to ULA 24-well plates and cultured in neural induction 
media consisting of DMEM/F12 medium, N2 supplement (1:100), 1x Glutamax, 1x MEM-NEAA and 1 
ʅg/mL heparin (Sigma; H3149). On day 6, contrary to the Lancaster et al. protocol, organoids were not 
added to matrigel droplets but continuously grown in ULA 24-well plates. Neural induction media was 
removed (at day 6) and replaced with differentiation media consisting of a mixture of Neurobasal 
medium and DMEM/F12 medium (1:1) supplemented with N2 supplement (1:200), B27 supplement 
without vitamin A (1:100; Invitrogen;12587010), 3.5 ʅl/L of ɴ-mercaptoethanol, Insulin (1:100; 
Sigma;I9278-5mL), Glutamax (1:100) and MEM-NEEA (1:200). On day 9, the differentiation media was 
exchanged for differentiation media containing B-27 supplemented with vitamin A (1:100; Gibco; 
17504-044). The eCOs were incubated for 2 days before being transferred to ULA 96-well plates 
containing either GBM1 or NP1 pre-made spheroids which were generated 24 hours before t0. 
eCO/GBM1 and eCO/NP1 were co-cultured in either GBM or NP media, respectively, for 48 hours. 
Following that time point, differentiation media containing B-27 supplemented with vitamin A was 
added in a proportion of 1:1.  
For real time imaging, ULA 96-well plates containing eCOs and GBM1 or NP1 spheroids were 
transferred to an IncuCyte ZOOM® live cell imaging system (Essen Bioscience) at t0. Phase contrast 
images were acquired for all conditions every 30 minutes over a period of 3 days using a 10x objective. 
Real time movies were compiled using the IncuCyte ZOOM® software package. 
Immunohistochemistry  
The eCO/GBM1 and eCO/NP1 fusion organoids were fixed with 4% (w/v) paraformaldehyde for 15 
minutes at 4°C. The tissues were subsequently washed three times with PBS and re-suspended in 30% 
(w/v) sucrose solution, and allowed to sink for 24 hours at 4°C. Once the organoids had sunk, they 
were embedded in OCT (VWR; 361603E) in cryo-ŵŽůĚƐĂŶĚƐĞĐƚŝŽŶĞĚŽŶĂĐƌǇŽƐƚĂƚ ? ? ?ʅŵƚŚŝĐŬŶĞƐƐ ? ? 
Images of every section of each individual organoid were taken and quantification of the GBM1 or NP1 
compartments was achieved through colour thresholding of the GFP positive cells using ImageJ 
(standard settings). Migration distances were measured using ImageJ (freehand lines tool).  
For immunohistochemistry, the sections were equilibrated in PBS, permeabilized with PBS containing 
0.2% (v/v) Triton X-100 for 10 minutes and incubated for 1 hour at room temperature with a PBS 
blocking/staining solution containing 0.03% (v/v) Triton X-100 and 10% (v/v) FBS. Next, the sections 
were incubated at 4°C overnight with the following primary antibodies: anti-TuJ1 (1:1000; Cambridge 
Bioscience; 801202), anti-GFAP (1:200; DAKO; Z0334), anti-KI67 (1:200; Abcam; Ab16667), anti-SOX2 
(1:150; Cell signalling; 35795), anti-VIMENTIN (1:200; DAKO; M0725), anti-NESTIN (1:200; Millipore; 
MAB5326), anti-MMP2 (1:50, Sigma, HPA001939), anti-MMP9 (1:200, Abcam, ab38898). VIMENTIN 
and NESTIN primary antibodies were human-specific, showing no cross-reactivity with mouse cells. 
The cells were then incubated for 1 hour at room temperature in the dark with the following secondary 
antibodies: Alexa-fluor-488 goat anti-mouse (1:200; Molecular Probes; A11029), and Alexa-fluor-Cy3 
(1:400; Jackson ImmunoResearch; 711-165-152). Nuclei were stained with  ?W/ ?  ?ʅŐ ?ŵ> ? ^ŝŐŵĂ ? 
D9542) and imaging was carried out using an EVOS digital inverted fluorescence microscope (Life 
Technologies) and a Nikon A1R confocal microscope. 
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Statistical analysis  
Data was analyzed by two-ƐŝĚĞĚƵŶƉĂŝƌĞĚ^ ƚƵĚĞŶƚ ?Ɛt-test and expressed as mean ± standard deviation 
(SD) ?EƌĞƉƌĞƐĞŶƚƐŝŶĚĞƉĞŶĚĞŶƚĞK ?'DĂŶĚĞK ?EWŚǇďƌŝĚƐ ?WǀĂůƵĞƐŽĨA? ? ? ?1 were considered 
highly significant. 
 
Results and Discussion 
To establish an experimental approach that was amenable to real time imaging and medium 
throughput (in a 96-well format), we separately generated eCOs and GBM spheroids (Figure 1A). The 
latter were generated from an established patient-derived GBM cell model (GBM1) which is 
characterized by stem cell-like features, including NESTIN/SOX2 co-expression as well as clonal 
growth, and in vivo tumorigenicity/invasion capacity.17, 19 Homogenous GBM spheroids were 
generated by aggregation of 500 GBM1 cells stably expressing green fluorescent protein (GFP). To 
maximize experimental throughput, we used a short mESCs differentiation period (12 days) that 
suffices to induce neural tissue identity in eCOs18 prior to the co-culture assay (Figure 1A). Qualitative 
immunohistological analysis showed the presence of the neuronal marker TuJ1 and distinct GFAP-
positive cells within the eCOs, thus confirming neural lineage commitment at day 12 (Supplementary 
image 1). Notably, we observed that the subsequent co-culture of GBM spheroids and eCOs for 48 
hours resulted in the spontaneous incorporation of GBM1 spheres into eCOs in 100% of cases, based 
on a total of 114 specimens across 7 different experimental sets (Figure 1B). Hybrid organoid 
formation was preceded by GBM spheroid/eCO fusion (as visualized by confocal microscopy after a 
16-hour co-culture period; Figure 1C). These results indicate a high reproducibility of GBM/eCO hybrid 
organoid formation. 
Based on the spontaneous infiltration of the eCOs by GBM cellular compartments, we next sought to 
address the dynamics of this process, and whether the hybrid-organoid phenotype was dependent on 
the cellular context (i.e., GBM versus NP). To this end, we utilized an adult brain-derived NESTIN and 
GFP-expressing NP line (NP1; originating from epilepsy surgery excess tissue17) (Supplementary image 
2) and generated 500-cell spheroid aggregates from GBM and NP cells, respectively. In agreement 
with reports describing fused cerebral organoids,20-21 time lapse microscopy experiments revealed 
that both GBM and NP spheroids first attached to, then fused with, and ultimately became 
incorporated into eCOs (Figure 2A, Supplementary movies 1 to 4; note that we refer to incorporated 
GBM and NP spheroids as GBM and NP compartments). However, the GBM spheroids showed a rapid 
incorporation with eCOs (resulting in hybrid eCO/GBM compartments <18 hours), whereas NP 
incorporation required a prolonged ƉĞƌŝŽĚ ?A? ? ?hours; 96% ± 3.7, n=70).  
Furthermore, histological analysis and image quantification showed a striking phenotypic difference 
between eCO/GBM and eCO/NP hybrid organoids (Figure 2B). When compared to their NP 
counterparts, the GBM compartments within eCO/GDŚǇďƌŝĚŽƌŐĂŶŽŝĚƐǁĞƌĞƐŝŐŶŝĨŝĐĂŶƚůǇůĂƌŐĞƌ ?A? ?-
fold) after a 52-hour co-culture period (Figure 2C). In addition, within the organoids, GBM cells 
displayed a significantly increased migration capacity at the 24-hour time point (Figure 2D). GBM cells 
consistently infiltrated the inner layers (core) of eCOs more effectively compared with their NP 
counterparts at the experimental endpoint (Figure 2E). Further qualitative immunohistological 
analysis of inner-layer GBM-compartments (using human-specific antibodies for GBM compartment 
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visualization) showed that the infiltrative GBM cells are characterized by co-expression of VIMENTIN 
and matrix metalloproteinase 2 (MMP2) proteins, which have been previously implicated in glioma 
invasion (Figure 3A and B; MMP9 immunopositivity was rarely detected, Supplementary image 3).22-23  
/ŶĂĚĚŝƚŝŽŶ ?ƚŚĞ'DĐĞůůƐĞǆƉƌĞƐƐĞĚƚŚĞŬŶŽǁŶ  ?ƐƚĞŵŶĞƐƐ ?ŵĂƌŬĞƌƐESTIN and SOX2 (Figure 3C). 
Expression of the cell cycle marker Ki67 was low/absent in the invasive GBM cell population, indicating 
a migratory rather than proliferative GBM cell phenotype (Supplementary image 4).   
In summary, our technical study demonstrates that co-culture of human GBM/NP spheroids and 
mESC-derived eCOs robustly resulted in the formation of hybrid cellular compartment organoids. We 
aimed to limit the experimental variability that is often associated with organoid methodology (e.g., 
reviewed in24). For example, long-term-cultured cerebral organoids have been reported to contain 
heterogeneous architectures and cellular diversity.18, 25 Thus, we utilized a short 12-day mESC 
differentiation period generating eCOs and a well-characterized patient-derived GBM cell model17, 19.  
Accordingly, we developed a reproducible and self-aggregating ex vivo experimental model system 
that aims, in real-time, to recapitulate the infiltrative characteristic of GBM that makes current 
therapy so ineffective. The use of standard (inverse) microscopy, live cell imaging and a medium-
throughput (96-well) assay format was made possible by eCO diameters of 300-800 µm. The resulting 
hybrid organoid sizes would allow for the use of 384-well (optical bottom) microtiter plates in 
medium/high-throughput screening applications, and automation of hybrid organoid dispension into 
microliter plates may be an option (note that a gel environment is currently not required for the assay). 
The protocol described herein may require significant modification(s) in regards with using the 1536-
well screening format.   
Importantly, the co-culture experiments indicated a significant difference in the infiltration capacity 
of GBM versus NP cells. Time-lapse microscopy identified the distinct phases of GBM/NP spheroid 
attachment and fusion, with tissue infiltration invasion exhibited exclusively by GBM cells. This hybrid 
organoid GBM invasion readout may complement limitations of mono-compartment assays, 
especially regarding identifying and distinguishing between molecular mechanisms that promote GBM 
cell migration and/or viability (e.g., utilizing chemical and/or genetic screens). The reported 
experimental approach is limited in being unable to observe migration of GBM cells along blood 
vessels and into the corpus callosum (evident in patient tumors26). Moreover, the results described 
are linked to the specific biological materials and protocols employed and hybrid organoid 
environment may substantially differ from the adult brain. Additional studies are required in terms of 
comparing stem cell-based organoids with other ex vivo glioma migration methodologies, including 
organotypic slice culture models.13-15 However, eCO/GBM hybrid organoids (and their non-cancerous 
controls) provide the foundation for the future development of high-throughput assays to investigate 
the underlying molecular mechanisms of invasion and screen for drugs that abrogate this phenotype. 
Future modifications of the assay may be based on the replacement of R1 mESCs with other (e.g., 
human) ESCs, and/or the replacement of the GBM1 stem cell-like model with other brain tumor cell 
models and/or freshly-isolated primary cells. Likewise, future studies may investigate hybrid organoid 
maturation and the development of GBM versus NP compartment phenotypes (e.g., with respect to 
quiescence and self-renewal capacity) over a prolonged (>2 months) culture period. 
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Figure 1. Investigation of neural tissue infiltration by free-floating GBM compared with NP spheroids 
through the co-culture with mouse embryonic stem cell (mESC)-derived eCOs. (A) Schematic overview 
of the experimental approach. The eCOs were formed from 2000 single mESCs, which were subjected 
to embryoid body formation, neural induction and differentiation. GBM (or NP) spheroid aggregates 
(GBMsp) consisted of 500 cells and were co-cultured with eCOs from day 12. (B) Representative 
immunofluorescence image of a well from a 96-well microtiter plate after a 48-hour GBMsp/eCO co-
culture period showing the formation of a hybrid organoid consisting of eCO and an infiltrative/green 
fluorescent protein (GFP)-positive GBM cell compartment. (C) Representative confocal microscopy 
image (volume view) showing fusion of GBM1-GFP cells (green) with eCO resulting in a migratory GBM 
cell phenotype (arrowhead). Green color indicates positive signal for GFP and nuclei (blue) were 
stained with DAPI.  
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Figure 2. Comparison of GBM and NP spheroid infiltration of eCOs. (A) Still frame images of GBM1 and 
NP spheroids invading eCOs taken over a time-lapse microscopy period of 52 hours. GBM and NP 
fusion results in cellular compartments (c) within the hybrid organoid structures. (B) Representative 
histological section montage of representative (entire) eCO/GBM and eCO/NP hybrid organoids. Note 
the overt difference in GBM versus NP compartment spread. (C) Quantification of GBM and NP cell 
compartment (c) sizes within hybrid eCO.  (D) Maximal migration distance of GBM and NP cells within 
eCOs. (E) Comparison of GBM and NP cellular compartments invading the eCO core, red bars represent 
the median. 
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Figure 3. Representative confocal microscopy immunofluorescence images (volume view) of the 
invasive GBM cellular compartment in histological sections of self-aggregated hybrid organoids 
(eCO/GBM). (A) False colors indicate VIMENTIN expression in GBM cells. Arrowhead highlights the 
migratory edge of GBM cells within the tissue. (B) False colors indicate Vimentin and MMP2 
immunopositivity and co-localization in GBM cells (highlighted with arrowheads). (C). False colors 
indicate positive staining for SOX2 and NESTIN in GBM cells (marker co-localization is highlighted with 
white arrowheads). Nuclei were stained with DAPI. 
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Supplementary images 
 
Supplementary image 1. Confocal microscopy immunofluorescence images of eCOs at day 12 of the 
neural induction protocol. False colors indicate positive signal for astrocytic marker GFAP (red) and 
neuronal marker TuJ1 (green). Nuclei (blue) were stained with DAPI. Upper panel: 20x objective. 
Lower panel: 100x objective. 
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Supplementary image 2. Immunofluorescence images of the GBM1 (left) and NP (right) cell models. 
Cells express NESTIN (false color: green) and proliferation marker Ki67 (false color: red). Nuclei (blue) 
were visualized with DAPI. 
 
 
 
 
Supplementary image 3. Representative confocal microscopy immunofluorescence image of the 
invasive GBM cellular compartment (eCO/GBM, volume view). False colors indicate positive signal 
for VIMENTIN (green) and rare signal for MMP9 (red). Nuclei (blue) were stained with DAPI.  
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Supplementary image 4. Representative confocal microscopy immunofluorescence image of the 
invasive GBM cellular compartment (eCO/GBM, volume view). False colors indicate positive signal 
for VIMENTIN (green) and negative signal for Ki67 (red). Nuclei (blue) were stained with DAPI.  
 
Supplementary Movie captions: 
Supplementary Movie 1 and 2: Representative time lapse microscopy imaging of GBM spheroid 
incorporation into eCOs. 
Supplementary Movie 3 and 4: Representative time lapse microscopy imaging of NP spheroid 
incorporation into eCOs. 
Throughout the GBM and NP spheroid infiltration experiments, varying degrees of cellular debris 
(stemming from eCO generation) and minor cellular necrosis (at the eCO peripheries) were 
observed.  
 
 
 
